Literature DB >> 15710212

New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA.

Fabien Zoulim1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15710212     DOI： 10.1016/j.jhep.2004.12.015

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  84 in total

1.  Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.

Authors:  Dawei Cai; Courtney Mills; Wenquan Yu; Ran Yan; Carol E Aldrich; Jeffry R Saputelli; William S Mason; Xiaodong Xu; Ju-Tao Guo; Timothy M Block; Andrea Cuconati; Haitao Guo
Journal:  Antimicrob Agents Chemother       Date:  2012-05-29       Impact factor: 5.191

Review 2.  Emerging drugs for hepatitis B.

Authors:  Fabien Zoulim
Journal:  Expert Opin Emerg Drugs       Date:  2007-05       Impact factor: 4.191

3.  Effects of antiviral agents and HBV genotypes on intrahepatic covalently closed circular DNA in HBeAg-positive chronic hepatitis B patients.

Authors:  Hai-Ying Lu; Li-Wei Zhuang; Yan-Yan Yu; Chong-Wen Si; Jun Li; Jian-Jun Zhang; Zheng Zeng; Xin-Yue Chen; Zhong-Hou Han; Yong Chen
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

Review 4.  The underlying mechanisms for the "simultaneous HBsAg and anti-HBs serological profile".

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

Review 5.  Occult hepatitis B virus infection and blood transfusion.

Authors:  Dong Hee Seo; Dong Hee Whang; Eun Young Song; Kyou Sup Han
Journal:  World J Hepatol       Date:  2015-03-27

6.  Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.

Authors:  Scott Bowden; Stephen Locarnini; Ting-Tsung Chang; You-Chen Chao; Kwang-Hyub Han; Robert G Gish; Robert A de Man; Miao Yu; Cyril Llamoso; Hong Tang
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

Review 7.  Eradication Strategies for Chronic Hepatitis B Infection.

Authors:  Eleanor M P Wilson; Lydia Tang; Shyam Kottilil
Journal:  Clin Infect Dis       Date:  2016-06-01       Impact factor: 9.079

8.  Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B: results from a nine-year longitudinal study.

Authors:  Tetsuya Hosaka; Fumitaka Suzuki; Masahiro Kobayashi; Yuya Seko; Yusuke Kawamura; Hitomi Sezaki; Norio Akuta; Yoshiyuki Suzuki; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Mariko Kobayashi; Hiromitsu Kumada
Journal:  J Gastroenterol       Date:  2012-10-12       Impact factor: 7.527

9.  A QSAR study on some series of anti-hepatitis B virus (HBV) agents.

Authors:  Preet K Arora; Vaishali M Patil; Satya P Gupta
Journal:  Bioinformation       Date:  2010-03-31

10.  Safety and efficacy of telbivudine for the treatment of chronic hepatitis B.

Authors:  Melissa K Osborn
Journal:  Ther Clin Risk Manag       Date:  2009-10-12       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.